Process evaluation of complex interventions in non-communicable and neglected tropical diseases in low- and middle-income countries: a scoping review.

coronary heart disease diabetes & endocrinology hypertension infectious diseases public health

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 09 2022
Historique:
entrez: 29 12 2022
pubmed: 30 12 2022
medline: 3 1 2023
Statut: epublish

Résumé

The aim of this review is to map out the use of process evaluation (PE) in complex interventions that address non-communicable diseases (NCDs) and neglected tropical diseases (NTDs) to identify gaps in the design and conduct, as well as strengths, limitations and implications, of this type of research in low- and middle-income countries (LMICs). Scoping review of PE studies of complex interventions implemented in LMICs. Six databases were searched focused on studies published since 2008. Embase, PubMed, EbscoHost, Web of Science (WOS), Virtual Health Library (VHL) Regional Portal and Global Index Medicus: Regional Indexes AIM (AFRO), LILACS (AMRO/PAHO), IMEMR (EMRO), IMSEAR (SEARO), WPRIM (WPRO) Global Index Regional Indexes, MEDLINE, SciELO. Studies conducted in LMICs on PEs of randomised controlled trials (RCTs) and non-RCTs published between January 2008 and January 2020. Other criteria were studies of interventions for people at risk or having physical and mental NCDs, and/or NTDs, and/or their healthcare providers and/or others related to achieve better health for these two disease groups. Studies were excluded if they were not reported in English or Spanish or Portuguese or French, not peer-reviewed articles, not empirical research and not human research. Data extracted to be evaluated were: available evidence in the utilisation of PE in the areas of NCDs and NTDs, including frameworks and theories used; methods applied to conduct PEs; and in a subsample, the barriers and facilitators to implement complex interventions identified through the PE. Variables were extracted and categorised. The information was synthesised through quantitative analysis by reporting frequencies and percentages. Qualitative analysis was also performed to understand facilitators and barriers presented in these studies. The implications for PEs, and how the information from the PE was used by researchers or other stakeholders were also assessed in this approach. 303 studies were identified, 79% were for NCDs, 12% used the label 'PE', 27% described a theory or framework for the PE, and 42% used mixed methods to analyse their findings. Acceptability, barriers and facilitators to implement the interventions, experiences and perceptions, and feasibility were the outcomes most frequently evaluated as part of the PEs. Barriers and facilitators themes identified were contextual factors, health system factors, human resources, attitudes and policy factors. PEs in NCDs and NTDs are used in LMICs with a wide variety of methods. This review identified many PEs that were not labelled by the authors as such, as well as a limited application of PE-related theories and frameworks, and heterogeneous reporting of this type of study.

Identifiants

pubmed: 36581963
pii: bmjopen-2021-057597
doi: 10.1136/bmjopen-2021-057597
pmc: PMC9438086
doi:

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e057597

Subventions

Organisme : Medical Research Council
ID : MR/K023233/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L002787/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Swiss Med Wkly. 2020 Sep 14;150:w20323
pubmed: 33022070
Transl Behav Med. 2020 Feb 3;10(1):168-178
pubmed: 30476259
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Lancet. 2011 Dec 10;378(9808):1986
pubmed: 30060392
BMC Health Serv Res. 2021 Feb 15;21(1):143
pubmed: 33588823
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
Syst Rev. 2019 Nov 7;8(1):266
pubmed: 31699136
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
BMJ. 2019 Dec 6;367:l6434
pubmed: 31810904
World Psychiatry. 2017 Oct;16(3):287-298
pubmed: 28941113
Syst Rev. 2021 Sep 7;10(1):244
pubmed: 34488877
Wellcome Open Res. 2020 Feb 10;5:23
pubmed: 32923686
PLoS One. 2016 Oct 20;11(10):e0164634
pubmed: 27764128
Lancet. 2020 Sep 26;396(10255):918-934
pubmed: 32891217
J Clin Epidemiol. 2016 Jul;75:40-6
pubmed: 27005575
Int J Chron Obstruct Pulmon Dis. 2017 Jul 20;12:2129-2139
pubmed: 28790816
Implement Sci. 2013 Aug 23;8:96
pubmed: 23972027
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
BMJ Open. 2019 Aug 6;9(8):e025127
pubmed: 31391188
PLoS One. 2018 Aug 23;13(8):e0202256
pubmed: 30138331
J Public Health Dent. 2011 Winter;71 Suppl 1:S7-15
pubmed: 21656942
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Yearb Med Inform. 2000;(1):65-70
pubmed: 27699347
Parasit Vectors. 2018 Apr 11;11(1):237
pubmed: 29642939
J Am Heart Assoc. 2019 Mar 19;8(6):e03984
pubmed: 30879371
PLoS Negl Trop Dis. 2016 Aug 25;10(8):e0004619
pubmed: 27561091
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Indian J Community Med. 2019 Oct;44(Suppl 1):S1-S2
pubmed: 31728078
Health Policy Plan. 2011 Sep;26(5):413-22
pubmed: 21149346
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
BMC Public Health. 2009 Dec 15;9:465
pubmed: 20003478
SSM Popul Health. 2017 Dec;3:255-265
pubmed: 29302612
Acta Trop. 2011 Sep;120 Suppl 1:S177-85
pubmed: 21439930
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Implement Sci. 2018 Jun 7;13(1):80
pubmed: 29879986
BMC Health Serv Res. 2020 Jan 29;20(1):65
pubmed: 31996195
BMC Health Serv Res. 2016 Aug 19;16(1):407
pubmed: 27538946
Glob Health Res Policy. 2019 Jul 05;4:19
pubmed: 31312722
BMC Health Serv Res. 2007 Sep 19;7:148
pubmed: 17880693
Health Policy Plan. 2017 Nov 1;32(suppl_4):iv13-iv26
pubmed: 28666336
BMC Health Serv Res. 2015 Mar 24;15:116
pubmed: 25889097
Syst Rev. 2016 Aug 15;5(1):138
pubmed: 27526851
Lancet. 2011 Apr 23;377(9775):1438-47
pubmed: 21474174

Auteurs

Maria Lazo-Porras (M)

CRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru maria.lazo.porras@gmail.com.
Division of Tropical and Humanitarian Medicine, University of Geneva and Geneva University Hospitals, Geneva, Switzerland.

Hueiming Liu (H)

The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Menglu Ouyang (M)

The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
The George Institute China at Peking University Health Science Center, Beijing, China.

Xuejun Yin (X)

The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
The George Institute China at Peking University Health Science Center, Beijing, China.

Alejandra Malavera (A)

The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Tiana Bressan (T)

University of Guelph, Ontario, Canada.

Wilmer Cristobal Guzman-Vilca (WC)

School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
Sociedad Científica de Estudiantes de Medicina Cayetano Heredia (SOCEMCH), Universidad Peruana Cayetano Heredia, Lima, Peru.

Niels Pacheco (N)

School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.

Melissa Benito (M)

CRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.

J Jaime Miranda (JJ)

CRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.

Graham Moore (G)

DECIPHer, UKCRC Centre of Excellence, Cardiff University, Cardiff, UK.

François Chappuis (F)

Division of Tropical and Humanitarian Medicine, University of Geneva and Geneva University Hospitals, Geneva, Switzerland.

Pablo Perel (P)

Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, UK.

David Beran (D)

Division of Tropical and Humanitarian Medicine, University of Geneva and Geneva University Hospitals, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH